#drug-shortage

[ follow ]
Alternative medicine
fromWIRED
1 week ago

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

FDA allowed compounding pharmacies a grace period to cease production post-drug shortage, but some continue to sell modified tirzepatide products.
#fda
Medicine
fromCbsnews
2 months ago

FDA declares end to Wegovy and Ozempic shortage

The FDA declared an end to the national shortage of Ozempic and Wegovy medications.
Novo Nordisk met and exceeded the U.S. demand for semaglutide products.
Medicine
fromWIRED
2 months ago

The Ozempic Shortage Is Over

The FDA has declared semaglutide no longer in shortage, affecting cheaper compounded versions and signaling significant market changes.
fromFast Company
6 months ago
Medicine

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over

Hims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.
fromwww.mercurynews.com
6 months ago
Medicine

Lilly weight-loss drug copycats dealt blow as shortage ends

Eli Lilly's medications are no longer in shortage, affecting the market for knockoff versions.
The FDA has resolved the shortage of Zepbound and Mounjaro, impacting compounded alternatives.
Medicine
fromCbsnews
2 months ago

FDA declares end to Wegovy and Ozempic shortage

The FDA declared an end to the national shortage of Ozempic and Wegovy medications.
Novo Nordisk met and exceeded the U.S. demand for semaglutide products.
Medicine
fromWIRED
2 months ago

The Ozempic Shortage Is Over

The FDA has declared semaglutide no longer in shortage, affecting cheaper compounded versions and signaling significant market changes.
fromFast Company
6 months ago
Medicine

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over

Hims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.
fromwww.mercurynews.com
6 months ago
Medicine

Lilly weight-loss drug copycats dealt blow as shortage ends

Eli Lilly's medications are no longer in shortage, affecting the market for knockoff versions.
The FDA has resolved the shortage of Zepbound and Mounjaro, impacting compounded alternatives.
more#fda
[ Load more ]